Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: phase 3 returned 4 record(s)
Monday, 07/30/2018
An Application of 2-In-1 Adaptive Phase 2/3 Design for Expedited Oncology Drug Development
Xinqun (Maggie) Chen, Merck & Co., Inc.; Linda Sun, Merck & Co., Inc.; Cong Chen, Merck & Co.
2:05 PM

Does Phase 2 PFS or ORR Predict Phase 3 OS?
Russell Reeve, Quintiles
2:50 PM

Tuesday, 07/31/2018
Testing Strategy in Phase 3 Trials with Multiple Doses
David Li, Pfizer; Simon Kirby, Pfizer
2:35 PM

Wednesday, 08/01/2018
Active Reference vs. Active Comparator: What Should We Include to Design Late-Phase Studies?
Suchitrita Rathmann, Eli Lilly & Co